Skip to main content
. 2021 Sep 15;44(11):1193–1208. doi: 10.1007/s40264-021-01111-w

Table 1.

Dimensions of stakeholder engagement for pharmacovigilance purposes [4]

Dimension Description
Breadth Quantity and diversity of stakeholders
Depth Extent of knowledge shared (in order of increasing depth: information, consultation and participation [5])
Texture Interactive dynamics of what the engagement feels like, what it means to people, and how this shapes motivations to engage and change behaviours based on values, emotions, (mis)trust and rationales